for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up
Healthcare

BRIEF-Crinetics Pharmaceuticals Reports Q4 Loss Per Share Of $0.60

March 9 (Reuters) - Crinetics Pharmaceuticals Inc:

* CRINETICS PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* CRINETICS PHARMACEUTICALS INC QUARTERLY LOSS PER SHARE $0.60

* CRINETICS PHARMACEUTICALS INC QUARTERLY GRANT REVENUES $321,000 VERSUS $781,000

* CRINETICS PHARMACEUTICALS - EXPECTS THAT CASH, CASH EQUIVALENTS AND INVESTMENTS WILL FUND CURRENT OPERATING PLAN INTO SECOND HALF OF 2021 Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up